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Abstract 
 
Background: To promote the utility of Chorionic 
Villous Sampling (CVS) for pre-natal diagnosis of beta 
thalassemia in at risk population and to highlight its 
demographic area distribution and effect of consanguinity. 
Method: This Cross Sectional Study was conducted in 
the Department of Gyne/Obstet-I, Holy Family Hospital, 
Rawalpindi, Pakistan, from June 1997 to June 2009. All 137 
couples having either a previously affected 
conceptus/child with thalassemia or having strong family 
history of thalassemia, were recruited for the test. Samples 
collected by standard procedure were sent to Armed Forces 
Institute of Pathology, Rawalpindi for thalassemia 
detection.  
Results: In 12 yrs 137 mothers underwent CVS. Mean 
gestational age at the time of procedure was 12.6 weeks. 
Consanguineous marriage was seen in 119 cases. Largest 
group was ‘Punjabis’. 126 couples had a previously 
affected child with homozygous beta thalassemia and 11 
had heterozygous beta thalassemia in their children. 95 
cases had a family history of the disease. After DNA 
analysis, 30 cases (22%) were diagnosed to have 
homozygous beta thalassemia while 77(56%) were having 
heterozygous beta thalassemia. Report was normal in 
remaining 30 cases (22%). Early spontaneous pregnancy 
loss was seen in only 02 cases.  
Conclusion: Thalassemia is one of the commonly 
inherited crippling disorders. Its familial transmission 
must be checked by effective public awareness 
programme, pre marital screening, genetic counseling and 
pre-natal diagnosis by CVS. 
Key Words: Chorionic Villous Sampling, Pre-Natal 
Diagnosis, beta- Thalassemia. 
 
Introduction 
 
Thalassaemias are a heterogeneous group of 
disorders in which the production of normal 
haemoglobin is partly or completely suppressed 
because of diminished synthesis of one or more globin 
chains. According to the chain, which is deficient, 
several types like α, ß and γ thalassaemias have been 
described 1.Thalassaemia was first identified as a 
clinical entity in 1925 by Thomas Cooley and Pearl Lee 
2 and more than a decade later, Wintrobe and 
colleagues described milder form of Cooley's anemia 
in both parents of the children with classic Cooley's 
anaemia 3.  
ß thalassemia is the commonest autosomal 
recessive single gene disorder of haemoglobin 
synthesis. In Pakistan it is one of the most frequent 
inherited disorders, with carrier rate of 5.4%4. 
Worldwide carrier frequency is 1.4-7.96 %5. Many 
social problems like preference to marry within same 
ethnic group/consanguineous marriages have 
contributed to its increased incidence.  
Chorionic Villous Sampling (CVS) was first 
introduced as a rapid means of pre natal diagnosis in 
early pregnancy in1980s6. For prenatal diagnosis, first 
trimester CVS is advantageous over second trimester 
amniocentesis7 because of less emotional and physical 
stress in early pregnancy in couples at risk, a less 
obvious pregnancy and therefore more privacy. 
Moreover, if termination of pregnancy is indicated, it 
can be done in such cases at a safer time. The first 
report of successful CVS8 for diagnosis of thalassemia 
was by Old et al. In Pakistan, prenatal diagnoses for -
thalassemia was introduced in 1994, Since then, the 
use of this service has increased from 26 in 1994 to 381 
in 2006.  Over 97% of the couples who requested 
prenatal diagnosis already had an affected child 9. To 
date, all over the world, multiple studies 3,4,8,10 have 
demonstrated high efficiency, safety and acceptability 
of the procedure suggesting that first trimester CVS 
should be the gold standard for prenatal diagnosis. 
Objective of our study was to promote the utility of the 
procedure and to give demographic area distribution 
of the disease with effect of consanguinity. 
 
Subjects and Methods 
 
All cases of CVS, done in our deptt for 
prenatal dignosis (PND) of ß thalassemia from 
June1997 – June2009 were studied retrospectively. 
Cases of PND for other chromosomal anomalies were 
not included. Couples were selected for the test after 
checking red cell indices and haemoglobin 
electrophoresis. After appropriate counseling of the 
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couple and a written consent, placental biopsy was 
taken under local analgesia with suction cannula by 
transabdominal approach. Specimen was sent in 0.9% 
Normal Saline  to Armed Forces Institute of Pathology 
(AFIP), where analysis of the sample was done by 
ARMS (Amplification Refractory Mutation System) 
method. This method is a modified variant of PCR 
method. Data was collected on pre designed proforma 
and was entered and analyzed through SPSS version 
10. For Quantitative variables (age, gestational age), 
means and standard deviation (S.D) were calculated 
and for Qualitative variables (demography, 
consanguinity, thalassemia), frequency and 
percentages were presented. 
 
Results 
 
In a 12-year period 137 mothers underwent 
CVS. Mothers were between the ages of 18-35 yrs. 
Mean maternal age was 27.4 yrs. Primigravida were 
only 04, mothers in their 2nd pregnancy were 21 and 
112 were in ≥ 3rd pregnancy.   
Consanguineous marriage was observed in 
119 cases; out of these 105 were 1st cousin and 14 
couples were relatives, while 18 couples were not 
related.  
126 couples had a previously affected child 
with homozygous beta thalassemia and 11 had 
heterozygous beta thalassemia in their children. 95 
cases had a family history of the disease but in 42 
couples there was no such history. 
CVS was attempted between the gestational 
ages of 07-23 weeks; mean gestational age at the time 
of procedure was 12.6 weeks.  
After DNA analysis, 30 cases (22%) were 
diagnosed having homozygous beta thalassemia while 
77(56%) were having heterozygous beta thalassemia. 
Report was normal in remaining 30 cases (22%). This 
disease distribution and consanguinity according to 
demographic area are shown in Table-1. 
Early spontaneous pregnancy loss was seen in 
only 02 cases. All couples having fetus with 
homozygous beta thalassemia opted for termination of 
pregnancy except for one couple. In later months of 
pregnancy, premature rupture of membranes was seen 
in 04 cases. 
 
Discussion 
 
Pregnant women of all ages should be offered 
screening and invasive diagnostic testing for 
chromosomal abnormalities before 20 weeks' 
gestation. Diagnostic options include CVS in the first 
trimester and amniocentesis in the second trimester 11. 
Introduction of first trimester screening programs has 
led to a decrease in the utilization of CVS, particularly 
among women 35 years or older 12. However as patient 
gets instant results in 60.6% of cases; this appears to 
increase the use of CVS 13.  
Over 200 mutations so far have been reported 
in β globin chain synthesis 14-16. Out of these, 25% have 
been found in heterogenous Indian population 17,18. 
Most of the children affected with this lethal disorder 
are born in developing countries 19,20.  
  In Pakistan there are 40,000 registered 
transfusion dependent thalassemic patients 4. CVS 
remains the gold standard for PND of β thalassemia. 
Procedure is simple and safe. All our CVS were 
successful and done in first attempt except 05 cases, 
which required interval attempt. No failure was seen. 
All mothers who underwent CVS were already having 
an affected child with thalasemia mutation and a 
strong family history of the disease was seen in 95% 
couples. Major groups studied were Punjabi and 
Pathan families, as referrals to our hospital are mainly 
from Punjab and NWFP. In both groups thalassemia 
frequency was very high. Such result was also seen in 
other studies 4.  
A carrier couple is at 25% risk of having a 
fetus with Cooleys anemia and at another 50 % risk of 
having a carrier child. In Punjabis, thalassemia was 
seen in 76% of our cases while 24 % were normal. In 
Pathan families this disease was in 82% cases. In both 
major groups studied, consanguinity was also high 
(86%, 88% resp.). The high prevalence of thalassemia 
in these areas is clearly explainable by the high degree 
of consanguinity, providing us a point for a breach in 
familial transmission of the disease. Countries like 
Greece, Italy, Iran, Iraq, Saudi Arabia and United Arab 
Emirates, where thalassemia mutation has almost 
come to an end, have achieved this goal by carefully 
designed health programme whereby inter-cousin 
marriages are discouraged. In our country cultural 
values are very religiously followed and there is very 
strong trend of marriage. within family for generation 
after generation. This practice is leading to an ever 
growing risk of increased transmission of, not only this 
autosomal recessive trait, but also of many other 
familial diseases. Affected families and country could 
be relieved of this avoidable burden only by effective 
public awareness programme, pre marital screening, 
genetic counseling and pre-natal diagnosis. In at risk 
population, inter cousin marriages should be 
discouraged . If both partners are carriers of the 
mutation they must be offered CVS in first trimester of 
pregnancy, so that a timely termination of pregnancy 
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with homozygous mutation could minimize the 
management load of this expensive disease. 
 
TABLE-1 Demograhic Area Distribution of beta-Thalassemia and Consanguinity 
Demographic 
Area 
Distribution 
No. Haemoglobinopathy n (%) Consanguinity 
      n (%) *Homozygous *Heterozygous    Normal  
Punjabi 100 26             (26) 50             (50) 24         (24) 86           (86) 
Pathan 34 03             (08) 25             (74) 06         (18) 30           (88) 
Hindko 02 01             (50) 01             (50) -- 02         (100) 
Afghan 01 -- 01            (100) -- 01         (100) 
*Homozygous beta Thalassemia  
*Heterozygous beta Thalassemia  
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